|1.||Giuliano, Anna R: 9 articles (05/2013 - 09/2002)|
|2.||Villa, Luisa L: 7 articles (12/2013 - 07/2002)|
|3.||Franco, Eduardo L: 6 articles (12/2013 - 07/2002)|
|4.||Schiller, John T: 6 articles (12/2011 - 01/2006)|
|5.||Christensen, Neil D: 6 articles (02/2011 - 02/2005)|
|6.||Palefsky, Joel M: 5 articles (10/2015 - 09/2003)|
|7.||Syrjänen, Kari: 5 articles (07/2012 - 10/2005)|
|8.||Schiffman, Mark: 4 articles (06/2015 - 09/2002)|
|9.||Bosch, F Xavier: 4 articles (01/2013 - 03/2002)|
|10.||Nyitray, Alan G: 4 articles (01/2013 - 08/2010)|
07/01/2012 - "Do neutralizing antibody responses generated by human papillomavirus infections favor a better outcome of low-grade cervical lesions?"
01/01/2012 - "Protection against papillomavirus infection is conferred by neutralizing antibodies directed towards the major structural protein L1. "
01/01/1998 - "Synthetic virus-like particles have been validated as vaccine against several animal papillomaviruses and used to map the seroepidemiology of the human papillomavirus infection, and define neutralizing antibodies. "
06/29/2006 - "These studies demonstrate that L2-based vaccines provide strong protection against experimental papillomavirus infection that is most likely based upon the induction of virus-neutralizing antibody. "
08/01/1996 - "Synthetic virus-like particles have been validated as vaccines for several animal papillomaviruses, and have been used to map the sero-epidemiology of human papillomavirus infection and to define papillomavirus neutralizing antibodies. "
|2.||DNA (Deoxyribonucleic Acid)IBA
03/17/1999 - "To test the efficacy of genetic vaccination against papillomavirus infection, plasmid DNA encoding cottontail rabbit papillomavirus (CRPV) E1, E2, E6, E7 or without insert were intramuscularly injected into five groups of rabbits. "
01/01/2005 - "The study was carried out on 100 patients with suspicious colposcopy findings (suggestive of human papillomavirus infection) who underwent a cervical smear for human papillomavirus testing DNA Hybrid Capture II and direct biopsies for histopathological analysis. "
11/01/1998 - "The purpose of this study was to determine the usefulness of the hybrid capture HPV DNA assay, a new nonradioactive solution hybridization assay, as a diagnostic tool for human papillomavirus infection. "
10/01/1993 - "[Detection of human papillomavirus DNA and clinicopathological study of vulvar human papillomavirus infection]."
05/01/1993 - "Diagnostic accuracy of the cytologic diagnosis of anal human papillomavirus infection compared with DNA hybridization studies."
04/21/2013 - "Randomized controlled trials conducted on several continents during the last 10 years have demonstrated that these vaccines are safe without serious side effects; they are highly immunogenic and efficacious in preventing incident and persistent vaccine-type human papillomavirus infections, high grade cervical, vulvar and vaginal intraepithelial neoplasia and so on. "
05/01/2009 - "A study was carried out in Bogota aimed at estimating the burden of disease associated with human papillomavirus infection (HPV) and the potentially avoidable percentage due to using new vaccines. "
03/01/2008 - "The cottontail rabbit papillomavirus (CRPV)/rabbit model has proved useful for the investigation of prophylactic and therapeutic vaccines and for the study of the pathogenesis of papillomavirus infection. "
02/01/2014 - "Knowledge of and attitude towards human papillomavirus infection and vaccines among nurses at a tertiary hospital in South Africa."
12/01/2013 - "Currently two vaccines are available to prevent the human papillomavirus infection and its associated diseases. "
|4.||Biological Markers (Surrogate Marker)IBA
07/01/2012 - "Biomarkers of oxidant load and type-specific clearance of prevalent oncogenic human papillomavirus infection: markers of immune response?"
06/01/2011 - "Risk estimates for persistent high-risk human papillomavirus infections as surrogate endpoints of progressive cervical disease critically depend on reference category: analysis of the combined prospective cohort of the New Independent States of the Former Soviet Union and Latin American Screening studies."
03/01/2013 - "[Biomarkers of cervical carcinogenesis associated with genital human papillomavirus infection]."
06/25/2004 - "Cell blocks can be prepared from residual thin-layer cervicovaginal (ThinPrep) material and can be used in immunohistochemical staining assays for p16INK4a and Ki-67, which are surrogate markers related to human papillomavirus infection and cell proliferation, respectively. "
09/01/2002 - "[Human papillomavirus infection, a possible biological marker of sexual behavior among university students]."
01/01/1986 - "Interferons have now been demonstrated to be effective in several forms of papillomavirus infection. "
05/27/2000 - "NEW ADMINISTRATION ROUTES: For genital papillomavirus infections, trials using systemic or intralesional administered interferon have not provided conclusive evidence but imiquimode appears to be quite promising. "
01/01/2011 - "Interferon-induced gene expression in cervical mucosa during human papillomavirus infection."
11/01/2002 - "The interferon system was studied in women with genital papillomavirus infection. "
01/01/2002 - "Production of interferons and change of the lymphocyte subpopulation phenotype in peripheral blood at cervical papillomavirus infection."
|6.||cidofovir (Vistide)FDA Link
09/01/2001 - "Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection."
09/01/2001 - "We report here what is to our knowledge the first double-blind, placebo-controlled study of the use of cidofovir, a nucleotide analogue, for the treatment of genital papillomavirus infections. "
09/01/2006 - "Our report provides further support for the use of intravenous cidofovir as therapy for treatment-resistant and/or widespread cutaneous human papillomavirus infection."
09/01/2006 - "Intravenous cidofovir-induced resolution of disfiguring cutaneous human papillomavirus infection."
12/01/2000 - "To the best of our knowledge, this is the first case in which topical cidofovir has been used for the treatment of a human papillomavirus infection of the oral mucosa."
12/01/2010 - "Plasma micronutrients and the acquisition and clearance of anal human papillomavirus infection: the Hawaii HPV cohort study."
06/15/2007 - "Hawaii cohort study of serum micronutrient concentrations and clearance of incident oncogenic human papillomavirus infection of the cervix."
06/01/2014 - "Micronutrients and supplements can reduce the risk of human papillomavirus infection, persistence, progression, and regression. "
01/01/2009 - "Odds ratio adjusted for age, smoking status, alcohol consumption, and human papillomavirus infection status revealed a significant gradient of decreasing risk of CIN 1, CIN 2/3, and cervical cancer with increasing serum concentrations of most antioxidant micronutrients. "
01/01/1998 - "There was no association between the plasma levels of these six micronutrients in women with cervical intraepithelial neoplasia and persistent human papillomavirus infection status in the placebo or the supplemented groups. "
06/01/1985 - "Papillomavirus infection among Japanese: an immunohistochemical study for papillomavirus genus-specific antigen in human surface epithelial lesions."
08/01/2015 - "The effect of human leukocyte antigen G alleles on human papillomavirus infection and persistence in a cohort of HIV-positive pregnant women from Brazil."
12/15/2009 - "Sublingual immunization with nonreplicating antigens induces antibody-forming cells and cytotoxic T cells in the female genital tract mucosa and protects against genital papillomavirus infection."
11/15/2005 - "Risk association between human leukocyte antigen-A allele and high-risk human papillomavirus infection for cervical neoplasia in Chinese women."
10/01/2005 - "Human leukocyte antigen (HLA) variations may affect immune response to human papillomavirus infection and subsequent cervical neoplasia risk. "
07/01/1987 - "Our preliminary data from this study suggest that 85% trichloroacetic acid is effective treatment of human papillomavirus infection of the cervix without dysplasia."
08/01/1990 - "Single application treatment of human papillomavirus infection of the cervix and vagina with trichloroacetic acid: a randomized trial."
07/01/1987 - "Trichloroacetic acid in the treatment of human papillomavirus infection of the cervix without associated dysplasia."
09/01/2013 - "Cervical cytokines and clearance of incident human papillomavirus infection: Hawaii HPV cohort study."
07/01/2012 - "Study the levels of cytokines in cervical mucus of women with transitory and persistent course of papillomavirus infection (PVI). "
08/01/2010 - "Elevated systemic levels of inflammatory cytokines in older women with persistent cervical human papillomavirus infection."
10/01/2003 - "The persistence of human papillomavirus infection in EV is thought to be a result of an immunogenetic defect, which determines the generation of several cytokines capable of down-regulating cell-mediated immunity. "
09/01/2001 - "[Efficiency of immunocorrection using cytokines in the therapy of papillomavirus infection]."
11/15/2010 - "Condom use is only partially protective against human papillomavirus infection. "
05/01/2008 - "To examine the evidence related to the efficacy of condom use versus the human papillomavirus vaccine in the prevention of human papillomavirus infections. "
01/01/2006 - "US study finds that consistent condom use protects against genital human papillomavirus infection."
03/01/2014 - "Condom use in prevention of Human Papillomavirus infections and cervical neoplasia: systematic review of longitudinal studies."
08/15/2010 - "Consistent condom use is associated with lower prevalence of human papillomavirus infection in men."
05/01/2007 - "Nevertheless, accumulating evidence from animal and clinical studies suggests that the enhancement of specific and innate immune responses is effective in clearance of the human papillomavirus infection, promoting a cautious optimism regarding the achievement of an efficacious immunotherapy. "
11/01/2002 - "Immunisation with HPV early proteins has been shown to have both prophylactic and therapeutic efficacy in animal papillomavirus infections and immunotherapies for low grade intra-epithelial lesions are realistic. "
04/01/1997 - "Successful treatment of a generalized human papillomavirus infection with granulocyte-macrophage colony-stimulating factor and interferon gamma immunotherapy in a patient with a primary immunodeficiency and cyclic neutropenia."
|3.||Male Circumcision (Circumcision)
01/01/2013 - "Male circumcision and prevalence of genital human papillomavirus infection in men: a multinational study."
05/15/2010 - "Circumcision of HIV-infected men: effects on high-risk human papillomavirus infections in a randomized trial in Rakai, Uganda."
11/01/2011 - "Male circumcision and human papillomavirus infection in men: a systematic review and meta-analysis."
11/01/2011 - "Circumcision and acquisition of human papillomavirus infection in young men."
01/01/2011 - "Association of low-risk human papillomavirus infection with male circumcision in young men: results from a longitudinal study conducted in Orange Farm (South Africa)."
|4.||Transplantation (Transplant Recipients)
08/01/2014 - "Improved detection reveals active β-papillomavirus infection in skin lesions from kidney transplant recipients."
11/01/2010 - "Human papillomavirus infection and anal dysplasia in renal transplant recipients."
01/15/2001 - "Human papillomavirus infection and anogenital condyloma in bone marrow transplant recipients."
10/30/1999 - "Human papillomavirus infections occur in 80% of patients 5 years after transplantation and can lead to malignant transformation. "
08/01/1996 - "Low prevalence of human papillomavirus infection of the cervix in renal transplant recipients."
11/01/1989 - "Evidence against diathermy as a beneficial treatment for human papillomavirus infection of the cervix."
11/01/1989 - "This data does not provide strong evidence that diathermy is appropriate management for women with cervical human papillomavirus infection without evidence of dysplasia."
11/01/1989 - "An observational study of the influence of diathermy on the rate of subsequent cytological evidence of cervical intraepithelial neoplasia and/or human papillomavirus infection among women with a histological diagnosis of cervical human papillomavirus infection is presented. "